ATE125541T1 - Reine kristalline form von rifapentin. - Google Patents

Reine kristalline form von rifapentin.

Info

Publication number
ATE125541T1
ATE125541T1 AT91911451T AT91911451T ATE125541T1 AT E125541 T1 ATE125541 T1 AT E125541T1 AT 91911451 T AT91911451 T AT 91911451T AT 91911451 T AT91911451 T AT 91911451T AT E125541 T1 ATE125541 T1 AT E125541T1
Authority
AT
Austria
Prior art keywords
crystalline form
pure crystalline
rifapentin
new pure
rifapentine
Prior art date
Application number
AT91911451T
Other languages
English (en)
Inventor
Marino Nebuloni
Emilio Occelli
Bruno Cavalleri
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Application granted granted Critical
Publication of ATE125541T1 publication Critical patent/ATE125541T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
AT91911451T 1990-06-29 1991-06-05 Reine kristalline form von rifapentin. ATE125541T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90112458 1990-06-29

Publications (1)

Publication Number Publication Date
ATE125541T1 true ATE125541T1 (de) 1995-08-15

Family

ID=8204159

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91911451T ATE125541T1 (de) 1990-06-29 1991-06-05 Reine kristalline form von rifapentin.

Country Status (13)

Country Link
EP (1) EP0536197B1 (de)
JP (1) JP3350861B2 (de)
KR (1) KR0170000B1 (de)
AT (1) ATE125541T1 (de)
BG (1) BG60980B2 (de)
CA (1) CA2082809C (de)
DE (1) DE69111607T2 (de)
DK (1) DK0536197T3 (de)
ES (1) ES2075454T3 (de)
HK (1) HK1005454A1 (de)
HU (1) HU211168A9 (de)
IE (1) IE68687B1 (de)
WO (1) WO1992000302A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE50212753D1 (de) 2001-07-26 2008-10-23 Alstom Technology Ltd Vormischbrenner mit hoher Flammenstabilität
ITMI20032144A1 (it) * 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
US7262236B2 (en) 2004-04-26 2007-08-28 Milliken & Company Acetal-based compositions
SI1698630T1 (sl) * 2005-03-03 2015-01-30 Alfa Wassermann S.P.A. Nove polimorfne oblike rifaksimina, postopki za njihovo pripravo in njihova uporaba v medicinskih pripravkih
US8952159B2 (en) 2009-12-28 2015-02-10 Silvio Massimo Lavagna Method for the production of amorphous rifaximin
IT1397107B1 (it) * 2009-12-28 2012-12-28 Lavagna Nuovo metodo per la preparazione di antibiotici in stato amorfo e prodotti ottenuti utilizzando detto metodo.
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
CN102079749B (zh) * 2010-11-25 2012-07-04 河北欣港药业有限公司 利福平原料药≤0.3g/ml及≥0.8g/ml密度规格的生产方法
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
CN103772413B (zh) * 2014-02-07 2016-01-20 天津大学 一种利福平ⅱ晶型的制备方法
US20240199642A1 (en) * 2021-04-21 2024-06-20 Interquim S.A. De C.V. Method for obtaining rifapentine with a new crystalline form

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1478563A (en) * 1975-03-05 1977-07-06 Lepetit Spa Rifamycin derivatives
GB8816620D0 (en) * 1988-07-13 1988-08-17 Lepetit Spa Rifapentine hydrohalides

Also Published As

Publication number Publication date
HU211168A9 (en) 1995-11-28
KR930701448A (ko) 1993-06-11
JPH05507690A (ja) 1993-11-04
DK0536197T3 (da) 1995-11-13
WO1992000302A1 (en) 1992-01-09
JP3350861B2 (ja) 2002-11-25
DE69111607T2 (de) 1995-12-21
BG60980B2 (bg) 1996-07-31
ES2075454T3 (es) 1995-10-01
IE68687B1 (en) 1996-07-10
EP0536197A1 (de) 1993-04-14
DE69111607D1 (de) 1995-08-31
EP0536197B1 (de) 1995-07-26
KR0170000B1 (ko) 1999-02-01
IE912266A1 (en) 1992-01-01
CA2082809C (en) 1995-10-17
HK1005454A1 (en) 1999-01-08

Similar Documents

Publication Publication Date Title
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
PT87820A (pt) Process for the preparation of 1,2,3,5,6-tetrahydro-pyridile anof pyperidile compounds and pharmaceutical compositions therewi
GB2210879B (en) 4h-1-benzopyran-4-one derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
EG18729A (en) Compound of n- amino - 1,2,4-triazinones used as insecticide.
FI925615A0 (fi) Stabiliserade farmaceutiska kompositioner, som innehaoller en hmg-coa-reduktas-inhibitorfoerening
ATE269290T1 (de) Benzoylderivate
SE8700498D0 (sv) Novel pharmaceologically active compounds
FI73995B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla 6,11-dihydro-dibenso-/b,e/-tiepin-11-n-alkyl- norskopinetrar.
MX9605741A (es) Clorhidrato cristalino del (r)-(-)-2-{n-[4-(1,1-dioxido-3-oxo-2,3-dihidro-benzisotiazol-2-il)-butil ]-aminometil} cromano.
ES2128519T3 (es) Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
NO890269D0 (no) Fremgangsmaate for fremstilling av 1,4-disubstituerte-piperidinyl-forbindelser.
IT1190824B (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
PT88994A (pt) Processo para a preparacao de 2',3'-didesoxi-2'-fluoro-nucleosidos e de composicoes farmaceuticas que os contem
DE69111607D1 (de) Reine kristalline form von rifapentin.
ES545260A0 (es) Procedimiento para la preparacion de una composicion pesti- cida
ITRM910430A1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
DK0417003T3 (da) Anvendelse af antiprogestomimetiske forbindelser til fremme af ovulation
DK0499157T3 (da) Fremgangsmåde til fremstilling af 1,3-dioxoler
GR3017348T3 (en) Novel isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same.
DE69017969D1 (de) 2-Cyclohexylpropionsäure oder Derivate davon enthaltende Riechstoffzusammensetzung.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
OA08630A (fr) Fraction immunogène active à l'égard des bilharzioses, sa préparation, compositions immunisantes la contenant.
SE9004169D0 (sv) Anvaendning av farmaceutiska och kosmetiska kompositioner, innehaallande 1,8-dihydroxi-10-fenyl-9-antron som verksam bestaandsdel
ATE53004T1 (de) Pharmazeutische zusammensetzungen mit inhalt von 5-phenyl-1,3-dioxoalkenylverbindungen.
FI903701A0 (fi) Reninhaemmande amino-oligohydroxiderivat.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time